Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease
-- FDA Sets PDUFA Goal Date of October 30, 202
The idea is to go long hoping to get the good news from the FDA.
-- FDA Sets PDUFA Goal Date of October 30, 202
The idea is to go long hoping to get the good news from the FDA.